Gen-Probe Relying On Tigris To Boost Overseas Blood Screen Market Share
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe projects a U.S. market launch in the first half of 2004 for its Tigris DTS fully automated, high-throughput molecular diagnostic instrument system
You may also be interested in...
West Nile assay
Chiron and Gen-Probe expect to file with FDA in early 2005 for their jointly developed West Nile virus blood donation screening assay for the Procleix Tigris automated nucleic acid testing system. The firms announced launch of an IND trial for the assay Sept. 1. The system will be tested in epidemic areas in Arizona, California, Colorado, Florida and Oklahoma to "improve the efficiency of high volume testing," they say (1"The Gray Sheet" Aug. 4, 2003, p. 21)...
West Nile assay
Chiron and Gen-Probe expect to file with FDA in early 2005 for their jointly developed West Nile virus blood donation screening assay for the Procleix Tigris automated nucleic acid testing system. The firms announced launch of an IND trial for the assay Sept. 1. The system will be tested in epidemic areas in Arizona, California, Colorado, Florida and Oklahoma to "improve the efficiency of high volume testing," they say (1"The Gray Sheet" Aug. 4, 2003, p. 21)...
Roche Tests Positive With FDA Panel: Hep B Blood Screen License Endorsed
Roche Molecular System's Cobas AmpliScreen hepatitis B virus nucleic acid test for whole blood is sensitive and specific enough to be licensed as a donor screen, according to FDA's Blood Products Advisory Committee